{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:53:13Z","timestamp":1791816793791,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00284-022-02921-6","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T14:02:36Z","timestamp":1657116156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["The Impact of D614G Mutation of SARS-COV-2 on the Efficacy of Anti-viral Drugs: A Comparative Molecular Docking and Molecular Dynamics Study"],"prefix":"10.1007","volume":"79","author":[{"given":"Alireza","family":"Poustforoosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hashemipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyeh","family":"Azadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Faramarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Pardakhty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Mehrabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-4077","authenticated-orcid":false,"given":"Mohammad Hadi","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"2921_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","volume":"182","author":"Q Wang","year":"2020","unstructured":"Wang Q, Wu J, Wang H et al (2020) Structural basis for RNA replication by the SARS-CoV-2 polymerase. Cell 182:417-428.e13. https:\/\/doi.org\/10.1016\/j.cell.2020.05.034","journal-title":"Cell"},{"key":"2921_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418\u2013423","journal-title":"J Med Virol"},{"key":"2921_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/nejmoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403\u2013416. https:\/\/doi.org\/10.1056\/nejmoa2035389","journal-title":"N Engl J Med"},{"key":"2921_CR4","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1056\/nejmoa2105290","volume":"385","author":"AR Falsey","year":"2021","unstructured":"Falsey AR, Sobieszczyk ME, Hirsch I et al (2021) Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine. N Engl J Med 385:2348\u20132360. https:\/\/doi.org\/10.1056\/nejmoa2105290","journal-title":"N Engl J Med"},{"key":"2921_CR5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1056\/nejmoa2107659","volume":"385","author":"PT Heath","year":"2021","unstructured":"Heath PT, Galiza EP, Baxter DN et al (2021) Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med 385:1172\u20131183. https:\/\/doi.org\/10.1056\/nejmoa2107659","journal-title":"N Engl J Med"},{"key":"2921_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.22062\/JKMU.2020.91474","volume":"27","author":"M Mehrabani","year":"2020","unstructured":"Mehrabani M, Raeiszadeh M, Najafipour H et al (2020) Evaluation of the cytotoxicity, antibacterial, antioxidant, and anti-inflammatory effects of different extracts of Punica granatum var. Pleniflora. J Kerman Univ Med Sci 27:414\u2013425. https:\/\/doi.org\/10.22062\/JKMU.2020.91474","journal-title":"J Kerman Univ Med Sci"},{"key":"2921_CR7","first-page":"3215","volume":"12","author":"RK Singla","year":"2021","unstructured":"Singla RK, He X, Chopra H et al (2021) Natural products for the prevention and control of the COVID-19 pandemic: sustainable bioresources. Front Pharmacol 12:3215","journal-title":"Front Pharmacol"},{"key":"2921_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.arcmed.2020.06.007","volume":"51","author":"S Vakili","year":"2020","unstructured":"Vakili S, Savardashtaki A, Jamalnia S et al (2020) Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Arch Med Res 51:603\u2013607. https:\/\/doi.org\/10.1016\/j.arcmed.2020.06.007","journal-title":"Arch Med Res"},{"key":"2921_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","volume":"80","author":"IM Ibrahim","year":"2020","unstructured":"Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky AA (2020) COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 80:554\u2013562. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.026","journal-title":"J Infect"},{"key":"2921_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"DS Hui","year":"2020","unstructured":"Hui DS, Azhar EI, Madani TA et al (2020) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91:264\u2013266","journal-title":"Int J Infect Dis"},{"key":"2921_CR11","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci 253:117592. https:\/\/doi.org\/10.1016\/j.lfs.2020.117592","journal-title":"Life Sci"},{"key":"2921_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"2921_CR13","doi-asserted-by":"publisher","first-page":"104445","DOI":"10.1016\/j.meegid.2020.104445","volume":"85","author":"S Laha","year":"2020","unstructured":"Laha S, Chakraborty J, Das S et al (2020) Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infect Genet Evol 85:104445. https:\/\/doi.org\/10.1016\/j.meegid.2020.104445","journal-title":"Infect Genet Evol"},{"key":"2921_CR14","doi-asserted-by":"publisher","first-page":"e1000197","DOI":"10.1371\/journal.ppat.1000197","volume":"4","author":"J Sui","year":"2008","unstructured":"Sui J, Aird DR, Tamin A et al (2008) Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog 4:e1000197. https:\/\/doi.org\/10.1371\/journal.ppat.1000197","journal-title":"PLoS Pathog"},{"key":"2921_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","volume":"183","author":"L Yurkovetskiy","year":"2020","unstructured":"Yurkovetskiy L, Wang X, Pascal KE et al (2020) Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183:739-751.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.09.032","journal-title":"Cell"},{"key":"2921_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber B, Fischer WM, Gnanakaran S et al (2020) Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182:812-827.e19. https:\/\/doi.org\/10.1016\/j.cell.2020.06.043","journal-title":"Cell"},{"key":"2921_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan M, Wu NC, Zhu X et al (2020) A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368:630\u2013633. https:\/\/doi.org\/10.1126\/science.abb7269","journal-title":"Science"},{"key":"2921_CR18","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00018-020-03580-1","volume":"78","author":"I Mercurio","year":"2021","unstructured":"Mercurio I, Tragni V, Busto F et al (2021) Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Cell Mol Life Sci 78:1501\u20131522. https:\/\/doi.org\/10.1007\/s00018-020-03580-1","journal-title":"Cell Mol Life Sci"},{"key":"2921_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.cell.2020.06.040","volume":"182","author":"ND Grubaugh","year":"2020","unstructured":"Grubaugh ND, Hanage WP, Rasmussen AL (2020) Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear. Cell 182:794\u2013795. https:\/\/doi.org\/10.1016\/j.cell.2020.06.040","journal-title":"Cell"},{"key":"2921_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00369-3","volume":"5","author":"CL Pierri","year":"2020","unstructured":"Pierri CL (2020) SARS-CoV-2 spike protein: flexibility as a new target for fighting infection. Signal Transduct Target Ther 5:1\u20133. https:\/\/doi.org\/10.1038\/s41392-020-00369-3","journal-title":"Signal Transduct Target Ther"},{"key":"2921_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.abd5223","volume":"370","author":"B Turo\u0148ov\u00e1","year":"2020","unstructured":"Turo\u0148ov\u00e1 B, Sikora M, Sch\u00fcrmann C et al (2020) In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. Science 370:203\u2013208. https:\/\/doi.org\/10.1126\/science.abd5223","journal-title":"Science"},{"key":"2921_CR22","unstructured":"A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways | medRxiv. https:\/\/pubmed.ncbi.nlm.nih.gov\/32511558\/. Accessed 2 Oct 2020"},{"key":"2921_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13167-021-00267-w","volume":"13","author":"V Tragni","year":"2022","unstructured":"Tragni V, Preziusi F, Laera L et al (2022) Modeling SARS-CoV-2 spike\/ACE2 protein\u2013protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context. EPMA J 13:149\u2013175. https:\/\/doi.org\/10.1007\/s13167-021-00267-w","journal-title":"EPMA J"},{"key":"2921_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","volume":"67","author":"JFW Chan","year":"2013","unstructured":"Chan JFW, Chan KH, Kao RYT et al (2013) Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 67:606\u2013616. https:\/\/doi.org\/10.1016\/j.jinf.2013.09.029","journal-title":"J Infect"},{"key":"2921_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y et al (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10:766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharm Sin B"},{"key":"2921_CR26","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","volume":"58","author":"J Dyall","year":"2014","unstructured":"Dyall J, Coleman CM, Hart BJ et al (2014) Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 58:4885\u20134893. https:\/\/doi.org\/10.1128\/AAC.03036-14","journal-title":"Antimicrob Agents Chemother"},{"key":"2921_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/bib\/bbaa288","volume":"22","author":"S Dotolo","year":"2021","unstructured":"Dotolo S, Marabotti A, Facchiano A, Tagliaferri R (2021) A review on drug repurposing applicable to COVID-19. Brief Bioinform 22:726\u2013741","journal-title":"Brief Bioinform"},{"key":"2921_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","volume":"14","author":"AS Omrani","year":"2014","unstructured":"Omrani AS, Saad MM, Baig K et al (2014) Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 14:1090\u20131095. https:\/\/doi.org\/10.1016\/S1473-3099(14)70920-X","journal-title":"Lancet Infect Dis"},{"key":"2921_CR29","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jiph.2020.06.016","volume":"13","author":"Y Kumar","year":"2020","unstructured":"Kumar Y, Singh H, Patel CN (2020) In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J Infect Public Health 13:1210\u20131223. https:\/\/doi.org\/10.1016\/j.jiph.2020.06.016","journal-title":"J Infect Public Health"},{"key":"2921_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cjce.24339","author":"A Poustforoosh","year":"2021","unstructured":"Poustforoosh A, Hashemipour H, Pardakhty A, Kalantari Pour M (2021) Preparation of nano-micelles of meloxicam for transdermal drug delivery and simulation of drug release: a computational supported experimental study. Can J Chem Eng. https:\/\/doi.org\/10.1002\/cjce.24339","journal-title":"Can J Chem Eng"},{"key":"2921_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini M, Bienert S, Waterhouse A et al (2014) SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:252\u2013258. https:\/\/doi.org\/10.1093\/nar\/gku340","journal-title":"Nucleic Acids Res"},{"key":"2921_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.6026\/97320630015572","volume":"15","author":"M Yadav","year":"2019","unstructured":"Yadav M (2019) Homology modeling and molecular dynamics dimulation study of \u03b2 carbonic anhydrase of Ascaris lumbricoides. Bioinformation 15:572\u2013578. https:\/\/doi.org\/10.6026\/97320630015572","journal-title":"Bioinformation"},{"key":"2921_CR33","doi-asserted-by":"publisher","first-page":"105632","DOI":"10.1016\/J.COMPBIOMED.2022.105632","volume":"146","author":"A Poustforoosh","year":"2022","unstructured":"Poustforoosh A, Faramarz S, Nematollahi MH et al (2022) In silico SELEX screening and statistical analysis of newly designed 5mer peptide-aptamers as Bcl-xl inhibitors using the Taguchi method. Comput Biol Med 146:105632. https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2022.105632","journal-title":"Comput Biol Med"},{"key":"2921_CR34","doi-asserted-by":"publisher","first-page":"106564","DOI":"10.1016\/j.bpc.2021.106564","volume":"272","author":"A Poustforoosh","year":"2021","unstructured":"Poustforoosh A, Hashemipour H, T\u00fcz\u00fcn B et al (2021) Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods. Biophys Chem 272:106564. https:\/\/doi.org\/10.1016\/j.bpc.2021.106564","journal-title":"Biophys Chem"},{"key":"2921_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/jcb.30178","volume":"123","author":"A Poustforoosh","year":"2022","unstructured":"Poustforoosh A, Faramarz S, Nematollahi MH et al (2022) 3D-QSAR, molecular docking, molecular dynamics, and ADME\/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma. J Cell Biochem 123:390\u2013405. https:\/\/doi.org\/10.1002\/jcb.30178","journal-title":"J Cell Biochem"},{"key":"2921_CR36","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1002\/prot.24694","volume":"82","author":"S Sirin","year":"2014","unstructured":"Sirin S, Pearlman DA, Sherman W (2014) Physics-based enzyme design: predicting binding affinity and catalytic activity. Protien Struct Funct Bioinform 82:3397\u20133409. https:\/\/doi.org\/10.1002\/prot.24694","journal-title":"Protien Struct Funct Bioinform"},{"key":"2921_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11224-020-01628-3","volume":"32","author":"U Panwar","year":"2021","unstructured":"Panwar U, Singh SK (2021) Atom-based 3D-QSAR, molecular docking, DFT, and simulation studies of acylhydrazone, hydrazine, and diazene derivatives as IN-LEDGF\/p75 inhibitors. Struct Chem 32:337\u2013352. https:\/\/doi.org\/10.1007\/s11224-020-01628-3","journal-title":"Struct Chem"},{"key":"2921_CR38","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1080\/07391102.2020.1763838","volume":"39","author":"P Taslimi","year":"2021","unstructured":"Taslimi P, Erden Y, Mamedov S et al (2021) The biological activities, molecular docking studies, and anticancer effects of 1-arylsuphonylpyrazole derivatives. J Biomol Struct Dyn 39:3336\u20133346. https:\/\/doi.org\/10.1080\/07391102.2020.1763838","journal-title":"J Biomol Struct Dyn"},{"key":"2921_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","volume":"54","author":"WL Jorgensen","year":"2002","unstructured":"Jorgensen WL, Duffy EM (2002) Prediction of drug solubility from structure. Adv Drug Deliv Rev 54:355\u2013366. https:\/\/doi.org\/10.1016\/S0169-409X(02)00008-X","journal-title":"Adv Drug Deliv Rev"},{"key":"2921_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","volume":"592","author":"JA Plante","year":"2021","unstructured":"Plante JA, Liu Y, Liu J et al (2021) Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592:116\u2013121. https:\/\/doi.org\/10.1038\/s41586-020-2895-3","journal-title":"Nature"},{"key":"2921_CR41","doi-asserted-by":"publisher","unstructured":"Tang L, Schulkins A, Chen CN, et al (2020) The SARS-CoV-2 Spike Protein D614G Mutation Shows Increasing Dominance and May Confer a Structural Advantage to the Furin Cleavage Domain. Preprints 1\u201314. https:\/\/doi.org\/10.20944\/preprints202005.0407.v1","DOI":"10.20944\/preprints202005.0407.v1"},{"key":"2921_CR42","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1021\/acschemneuro.0c00596","volume":"11","author":"R Butowt","year":"2020","unstructured":"Butowt R, Bilinska K, Von Bartheld CS (2020) Chemosensory dysfunction in COVID-19: integration of genetic and epidemiological data points to D614G spike protein variant as a contributing factor. ACS Chem Neurosci 11:3180\u20133184. https:\/\/doi.org\/10.1021\/acschemneuro.0c00596","journal-title":"ACS Chem Neurosci"},{"key":"2921_CR43","doi-asserted-by":"publisher","unstructured":"Hu J, He CL, Gao QZ, et al (2020) D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity. bioRxiv 1\u201337. https:\/\/doi.org\/10.1101\/2020.06.20.161323","DOI":"10.1101\/2020.06.20.161323"},{"key":"2921_CR44","doi-asserted-by":"publisher","first-page":"14031","DOI":"10.1038\/s41598-020-70827-z","volume":"10","author":"S Isabel","year":"2020","unstructured":"Isabel S, Gra\u00f1a-Miraglia L, Gutierrez JM et al (2020) Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. Sci Rep 10:14031. https:\/\/doi.org\/10.1038\/s41598-020-70827-z","journal-title":"Sci Rep"},{"key":"2921_CR45","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1021\/acs.jcim.0c00575","volume":"60","author":"D Su\u00e1rez","year":"2020","unstructured":"Su\u00e1rez D, D\u00edaz N (2020) SARS-CoV-2 main protease: a molecular dynamics study. J Chem Inf Model 60:5815\u20135831. https:\/\/doi.org\/10.1021\/acs.jcim.0c00575","journal-title":"J Chem Inf Model"},{"key":"2921_CR46","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1080\/07391102.2020.1763201","volume":"39","author":"S Das","year":"2021","unstructured":"Das S, Sarmah S, Lyndem S, Singha Roy A (2021) An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn 39:3347\u20133357. https:\/\/doi.org\/10.1080\/07391102.2020.1763201","journal-title":"J Biomol Struct Dyn"},{"key":"2921_CR47","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.bbrc.2020.10.054","volume":"534","author":"G Asadikaram","year":"2020","unstructured":"Asadikaram G, Poustforoosh A, Pardakhty A et al (2020) Niosomal virosome derived by vesicular stomatitis virus glycoprotein as a new gene carrier. Biochem Biophys Res Commun 534:980\u2013987. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.054","journal-title":"Biochem Biophys Res Commun"},{"key":"2921_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jconrel.2022.02.015","volume":"343","author":"A Poustforoosh","year":"2022","unstructured":"Poustforoosh A, Nematollahi MH, Hashemipour H, Pardakhty A (2022) Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles. J Control Release 343:777\u2013797. https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.015","journal-title":"J Control Release"},{"key":"2921_CR49","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/jvi.77.2.841-850.2003","volume":"77","author":"JC Tsai","year":"2003","unstructured":"Tsai JC, Zelus BD, Holmes KV, Weiss SR (2003) The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J Virol 77:841\u2013850. https:\/\/doi.org\/10.1128\/jvi.77.2.841-850.2003","journal-title":"J Virol"},{"key":"2921_CR50","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/jcc.26383","volume":"41","author":"IO Omotuyi","year":"2020","unstructured":"Omotuyi IO, Nash O, Ajiboye OB et al (2020) Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2. J Comput Chem 41:2158\u20132161. https:\/\/doi.org\/10.1002\/jcc.26383","journal-title":"J Comput Chem"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-02921-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T04:06:05Z","timestamp":1657857965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-02921-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2921"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-02921-6","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent on Studies with Human and Animal Subjects"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"241"}}